SOCIEDADE BENEF ISRAELITABRAS HOSPITAL ALBERT EINSTEIN
🇧🇷Brazil
- Country
- 🇧🇷Brazil
- Ownership
- Private
- Established
- 1971-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- https://www.einstein.br
Clinical Trials
143
Active:9
Completed:64
Trial Phases
5 Phases
Phase 1:5
Phase 2:10
Phase 3:13
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (110 trials with phase data)• Click on a phase to view related trials
Not Applicable
80 (72.7%)Phase 3
13 (11.8%)Phase 2
10 (9.1%)Phase 1
5 (4.5%)Phase 4
2 (1.8%)e-Natureza Blue Care: Nature-based Virtual Reality and Pain Perception
Not Applicable
Not yet recruiting
- Conditions
- Cancer PainPalliative Care
- Interventions
- Behavioral: Nature-based virtual realityDrug: Standard Pain Management
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 130
- Registration Number
- NCT07053228
- Locations
- 🇧🇷
Hospital Albert Einstein, São Paulo, SP, Brazil
Acute Treatment and Long-term Assessment of Adult Infectious Meningitis
Not yet recruiting
- Conditions
- Viral MeningitisBacterial MeningitisFungal MeningitisMeningitis
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 624
- Registration Number
- NCT07027475
Feasibility Study to Actively Disseminate the Latin America and the Caribbean Code Against Cancer in Primary Healthcare Centers
Not Applicable
Not yet recruiting
- Conditions
- CancerLatin America and the Caribbean Code Against Cancer (LAC Code)
- First Posted Date
- 2025-05-11
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 1200
- Registration Number
- NCT06965608
- Locations
- 🇧🇷
HMAP - Hospital Municipal de Aparecida de Goiânia, Aparecida de Goiania, GO, Brazil
"Immunoregulation in Atherosclerosis: A Single-Cell RNA Sequencing Study"
Not yet recruiting
- Conditions
- Atherosclerosis of Coronary Artery
- First Posted Date
- 2025-03-06
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 30
- Registration Number
- NCT06860295
- Locations
- 🇧🇷
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil
A Multifaceted Intervention on Reducing Immunization Errors
Not Applicable
Not yet recruiting
- Conditions
- VaccinesVaccines Adverse ReactionVaccine Practice
- First Posted Date
- 2024-12-20
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 72
- Registration Number
- NCT06745635
- Locations
- 🇧🇷
Hospital Israelita Albert Einstein, Sao Paulo, Brazil
- Prev
- 1
- 2
- 3
- 4
- 5
- 27
- Next
News
No news found